Global Monkeypox Vaccine Market Growth 2023-2029

February 2023 | 74 pages | ID: GD58957F6780EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Monkeypox is a viral zoonosis (a virus transmitted to humans from animals) with symptoms very similar to those seen in the past in smallpox patients, although it is clinically less severe. With the eradication of smallpox in 1980 and subsequent cessation of smallpox vaccination, monkeypox has emerged as the most important orthopoxvirus for public health. Monkeypox primarily occurs in Central and West Africa, often in proximity to tropical rainforests and has been increasingly appearing in urban areas. Animal hosts include a range of rodents and non-human primates.

LPI (LP Information)' newest research report, the “Monkeypox Vaccine Industry Forecast” looks at past sales and reviews total world Monkeypox Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Monkeypox Vaccine sales for 2023 through 2029. With Monkeypox Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monkeypox Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Monkeypox Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monkeypox Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Monkeypox Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monkeypox Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monkeypox Vaccine.

The global Monkeypox Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Monkeypox Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Monkeypox Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Monkeypox Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Monkeypox Vaccine players cover Bavarian Nordic inks, Emergent BioSolutions and SIGA Technologies, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Monkeypox Vaccine market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• DNA
• Non-replicating Viral Vector
• Protein Subunit
• RNA
• Others

Segmentation by application

• Aldult
• Child

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bavarian Nordic inks
• Emergent BioSolutions
• SIGA Technologies, Inc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Monkeypox Vaccine market?

What factors are driving Monkeypox Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Monkeypox Vaccine market opportunities vary by end market size?

How does Monkeypox Vaccine break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Monkeypox Vaccine Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Monkeypox Vaccine by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Monkeypox Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Monkeypox Vaccine Segment by Type
  2.2.1 DNA
  2.2.2 Non-replicating Viral Vector
  2.2.3 Protein Subunit
  2.2.4 RNA
  2.2.5 Others
2.3 Monkeypox Vaccine Sales by Type
  2.3.1 Global Monkeypox Vaccine Sales Market Share by Type (2018-2023)
  2.3.2 Global Monkeypox Vaccine Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Monkeypox Vaccine Sale Price by Type (2018-2023)
2.4 Monkeypox Vaccine Segment by Application
  2.4.1 Aldult
  2.4.2 Child
2.5 Monkeypox Vaccine Sales by Application
  2.5.1 Global Monkeypox Vaccine Sale Market Share by Application (2018-2023)
  2.5.2 Global Monkeypox Vaccine Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Monkeypox Vaccine Sale Price by Application (2018-2023)

3 GLOBAL MONKEYPOX VACCINE BY COMPANY

3.1 Global Monkeypox Vaccine Breakdown Data by Company
  3.1.1 Global Monkeypox Vaccine Annual Sales by Company (2018-2023)
  3.1.2 Global Monkeypox Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Monkeypox Vaccine Annual Revenue by Company (2018-2023)
  3.2.1 Global Monkeypox Vaccine Revenue by Company (2018-2023)
  3.2.2 Global Monkeypox Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Monkeypox Vaccine Sale Price by Company
3.4 Key Manufacturers Monkeypox Vaccine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Monkeypox Vaccine Product Location Distribution
  3.4.2 Players Monkeypox Vaccine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR MONKEYPOX VACCINE BY GEOGRAPHIC REGION

4.1 World Historic Monkeypox Vaccine Market Size by Geographic Region (2018-2023)
  4.1.1 Global Monkeypox Vaccine Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Monkeypox Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Monkeypox Vaccine Market Size by Country/Region (2018-2023)
  4.2.1 Global Monkeypox Vaccine Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Monkeypox Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Monkeypox Vaccine Sales Growth
4.4 APAC Monkeypox Vaccine Sales Growth
4.5 Europe Monkeypox Vaccine Sales Growth
4.6 Middle East & Africa Monkeypox Vaccine Sales Growth

5 AMERICAS

5.1 Americas Monkeypox Vaccine Sales by Country
  5.1.1 Americas Monkeypox Vaccine Sales by Country (2018-2023)
  5.1.2 Americas Monkeypox Vaccine Revenue by Country (2018-2023)
5.2 Americas Monkeypox Vaccine Sales by Type
5.3 Americas Monkeypox Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Monkeypox Vaccine Sales by Region
  6.1.1 APAC Monkeypox Vaccine Sales by Region (2018-2023)
  6.1.2 APAC Monkeypox Vaccine Revenue by Region (2018-2023)
6.2 APAC Monkeypox Vaccine Sales by Type
6.3 APAC Monkeypox Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Monkeypox Vaccine by Country
  7.1.1 Europe Monkeypox Vaccine Sales by Country (2018-2023)
  7.1.2 Europe Monkeypox Vaccine Revenue by Country (2018-2023)
7.2 Europe Monkeypox Vaccine Sales by Type
7.3 Europe Monkeypox Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Monkeypox Vaccine by Country
  8.1.1 Middle East & Africa Monkeypox Vaccine Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Monkeypox Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Monkeypox Vaccine Sales by Type
8.3 Middle East & Africa Monkeypox Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Monkeypox Vaccine
10.3 Manufacturing Process Analysis of Monkeypox Vaccine
10.4 Industry Chain Structure of Monkeypox Vaccine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Monkeypox Vaccine Distributors
11.3 Monkeypox Vaccine Customer

12 WORLD FORECAST REVIEW FOR MONKEYPOX VACCINE BY GEOGRAPHIC REGION

12.1 Global Monkeypox Vaccine Market Size Forecast by Region
  12.1.1 Global Monkeypox Vaccine Forecast by Region (2024-2029)
  12.1.2 Global Monkeypox Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Monkeypox Vaccine Forecast by Type
12.7 Global Monkeypox Vaccine Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Bavarian Nordic inks
  13.1.1 Bavarian Nordic inks Company Information
  13.1.2 Bavarian Nordic inks Monkeypox Vaccine Product Portfolios and Specifications
  13.1.3 Bavarian Nordic inks Monkeypox Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Bavarian Nordic inks Main Business Overview
  13.1.5 Bavarian Nordic inks Latest Developments
13.2 Emergent BioSolutions
  13.2.1 Emergent BioSolutions Company Information
  13.2.2 Emergent BioSolutions Monkeypox Vaccine Product Portfolios and Specifications
  13.2.3 Emergent BioSolutions Monkeypox Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Emergent BioSolutions Main Business Overview
  13.2.5 Emergent BioSolutions Latest Developments
13.3 SIGA Technologies, Inc.
  13.3.1 SIGA Technologies, Inc. Company Information
  13.3.2 SIGA Technologies, Inc. Monkeypox Vaccine Product Portfolios and Specifications
  13.3.3 SIGA Technologies, Inc. Monkeypox Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 SIGA Technologies, Inc. Main Business Overview
  13.3.5 SIGA Technologies, Inc. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Monkeypox Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Monkeypox Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of DNA
Table 4. Major Players of Non-replicating Viral Vector
Table 5. Major Players of Protein Subunit
Table 6. Major Players of RNA
Table 7. Major Players of Others
Table 8. Global Monkeypox Vaccine Sales by Type (2018-2023) & (K Units)
Table 9. Global Monkeypox Vaccine Sales Market Share by Type (2018-2023)
Table 10. Global Monkeypox Vaccine Revenue by Type (2018-2023) & ($ million)
Table 11. Global Monkeypox Vaccine Revenue Market Share by Type (2018-2023)
Table 12. Global Monkeypox Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Monkeypox Vaccine Sales by Application (2018-2023) & (K Units)
Table 14. Global Monkeypox Vaccine Sales Market Share by Application (2018-2023)
Table 15. Global Monkeypox Vaccine Revenue by Application (2018-2023)
Table 16. Global Monkeypox Vaccine Revenue Market Share by Application (2018-2023)
Table 17. Global Monkeypox Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Monkeypox Vaccine Sales by Company (2018-2023) & (K Units)
Table 19. Global Monkeypox Vaccine Sales Market Share by Company (2018-2023)
Table 20. Global Monkeypox Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Monkeypox Vaccine Revenue Market Share by Company (2018-2023)
Table 22. Global Monkeypox Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Monkeypox Vaccine Producing Area Distribution and Sales Area
Table 24. Players Monkeypox Vaccine Products Offered
Table 25. Monkeypox Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Monkeypox Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Monkeypox Vaccine Sales Market Share Geographic Region (2018-2023)
Table 30. Global Monkeypox Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Monkeypox Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Monkeypox Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Monkeypox Vaccine Sales Market Share by Country/Region (2018-2023)
Table 34. Global Monkeypox Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Monkeypox Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Monkeypox Vaccine Sales by Country (2018-2023) & (K Units)
Table 37. Americas Monkeypox Vaccine Sales Market Share by Country (2018-2023)
Table 38. Americas Monkeypox Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Monkeypox Vaccine Revenue Market Share by Country (2018-2023)
Table 40. Americas Monkeypox Vaccine Sales by Type (2018-2023) & (K Units)
Table 41. Americas Monkeypox Vaccine Sales by Application (2018-2023) & (K Units)
Table 42. APAC Monkeypox Vaccine Sales by Region (2018-2023) & (K Units)
Table 43. APAC Monkeypox Vaccine Sales Market Share by Region (2018-2023)
Table 44. APAC Monkeypox Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Monkeypox Vaccine Revenue Market Share by Region (2018-2023)
Table 46. APAC Monkeypox Vaccine Sales by Type (2018-2023) & (K Units)
Table 47. APAC Monkeypox Vaccine Sales by Application (2018-2023) & (K Units)
Table 48. Europe Monkeypox Vaccine Sales by Country (2018-2023) & (K Units)
Table 49. Europe Monkeypox Vaccine Sales Market Share by Country (2018-2023)
Table 50. Europe Monkeypox Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Monkeypox Vaccine Revenue Market Share by Country (2018-2023)
Table 52. Europe Monkeypox Vaccine Sales by Type (2018-2023) & (K Units)
Table 53. Europe Monkeypox Vaccine Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Monkeypox Vaccine Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Monkeypox Vaccine Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Monkeypox Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Monkeypox Vaccine Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Monkeypox Vaccine Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Monkeypox Vaccine Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Monkeypox Vaccine
Table 61. Key Market Challenges & Risks of Monkeypox Vaccine
Table 62. Key Industry Trends of Monkeypox Vaccine
Table 63. Monkeypox Vaccine Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Monkeypox Vaccine Distributors List
Table 66. Monkeypox Vaccine Customer List
Table 67. Global Monkeypox Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Monkeypox Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Monkeypox Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Monkeypox Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Monkeypox Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Monkeypox Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Monkeypox Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Monkeypox Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Monkeypox Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Monkeypox Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Monkeypox Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Monkeypox Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Monkeypox Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Monkeypox Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Bavarian Nordic inks Basic Information, Monkeypox Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 82. Bavarian Nordic inks Monkeypox Vaccine Product Portfolios and Specifications
Table 83. Bavarian Nordic inks Monkeypox Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Bavarian Nordic inks Main Business
Table 85. Bavarian Nordic inks Latest Developments
Table 86. Emergent BioSolutions Basic Information, Monkeypox Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. Emergent BioSolutions Monkeypox Vaccine Product Portfolios and Specifications
Table 88. Emergent BioSolutions Monkeypox Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Emergent BioSolutions Main Business
Table 90. Emergent BioSolutions Latest Developments
Table 91. SIGA Technologies, Inc. Basic Information, Monkeypox Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 92. SIGA Technologies, Inc. Monkeypox Vaccine Product Portfolios and Specifications
Table 93. SIGA Technologies, Inc. Monkeypox Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. SIGA Technologies, Inc. Main Business
Table 95. SIGA Technologies, Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Monkeypox Vaccine
Figure 2. Monkeypox Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Monkeypox Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Monkeypox Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Monkeypox Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of DNA
Figure 10. Product Picture of Non-replicating Viral Vector
Figure 11. Product Picture of Protein Subunit
Figure 12. Product Picture of RNA
Figure 13. Product Picture of Others
Figure 14. Global Monkeypox Vaccine Sales Market Share by Type in 2022
Figure 15. Global Monkeypox Vaccine Revenue Market Share by Type (2018-2023)
Figure 16. Monkeypox Vaccine Consumed in Aldult
Figure 17. Global Monkeypox Vaccine Market: Aldult (2018-2023) & (K Units)
Figure 18. Monkeypox Vaccine Consumed in Child
Figure 19. Global Monkeypox Vaccine Market: Child (2018-2023) & (K Units)
Figure 20. Global Monkeypox Vaccine Sales Market Share by Application (2022)
Figure 21. Global Monkeypox Vaccine Revenue Market Share by Application in 2022
Figure 22. Monkeypox Vaccine Sales Market by Company in 2022 (K Units)
Figure 23. Global Monkeypox Vaccine Sales Market Share by Company in 2022
Figure 24. Monkeypox Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Monkeypox Vaccine Revenue Market Share by Company in 2022
Figure 26. Global Monkeypox Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Monkeypox Vaccine Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Monkeypox Vaccine Sales 2018-2023 (K Units)
Figure 29. Americas Monkeypox Vaccine Revenue 2018-2023 ($ Millions)
Figure 30. APAC Monkeypox Vaccine Sales 2018-2023 (K Units)
Figure 31. APAC Monkeypox Vaccine Revenue 2018-2023 ($ Millions)
Figure 32. Europe Monkeypox Vaccine Sales 2018-2023 (K Units)
Figure 33. Europe Monkeypox Vaccine Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Monkeypox Vaccine Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Monkeypox Vaccine Revenue 2018-2023 ($ Millions)
Figure 36. Americas Monkeypox Vaccine Sales Market Share by Country in 2022
Figure 37. Americas Monkeypox Vaccine Revenue Market Share by Country in 2022
Figure 38. Americas Monkeypox Vaccine Sales Market Share by Type (2018-2023)
Figure 39. Americas Monkeypox Vaccine Sales Market Share by Application (2018-2023)
Figure 40. United States Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Monkeypox Vaccine Sales Market Share by Region in 2022
Figure 45. APAC Monkeypox Vaccine Revenue Market Share by Regions in 2022
Figure 46. APAC Monkeypox Vaccine Sales Market Share by Type (2018-2023)
Figure 47. APAC Monkeypox Vaccine Sales Market Share by Application (2018-2023)
Figure 48. China Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Monkeypox Vaccine Sales Market Share by Country in 2022
Figure 56. Europe Monkeypox Vaccine Revenue Market Share by Country in 2022
Figure 57. Europe Monkeypox Vaccine Sales Market Share by Type (2018-2023)
Figure 58. Europe Monkeypox Vaccine Sales Market Share by Application (2018-2023)
Figure 59. Germany Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Monkeypox Vaccine Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Monkeypox Vaccine Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Monkeypox Vaccine Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Monkeypox Vaccine Sales Market Share by Application (2018-2023)
Figure 68. Egypt Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Monkeypox Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Monkeypox Vaccine in 2022
Figure 74. Manufacturing Process Analysis of Monkeypox Vaccine
Figure 75. Industry Chain Structure of Monkeypox Vaccine
Figure 76. Channels of Distribution
Figure 77. Global Monkeypox Vaccine Sales Market Forecast by Region (2024-2029)
Figure 78. Global Monkeypox Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Monkeypox Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Monkeypox Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Monkeypox Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Monkeypox Vaccine Revenue Market Share Forecast by Application (2024-2029)